Your browser doesn't support javascript.
loading
Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working group.
Narayan, Vivek; Harrison, Michael; Cheng, Heather; Kenfield, Stacey; Aggarwal, Rahul; Kwon, Daniel; McKay, Rana; Hauger, Richard; Hart, Nicolas; Conzen, Suzanne; Borno, Hala; Jim, Heather; Dicker, Adam; Dorff, Tanya; Moslehi, Javid; Mucci, Lorelei; Parsons, J Kellogg; Saad, Fred; Soule, Howard; Morgans, Alicia; Ryan, Charles J.
Afiliação
  • Narayan V; Division of Hematology/Medical Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Harrison M; Duke University Medical Center, Durham, NC.
  • Cheng H; University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Kenfield S; Department of Urology, University of California San Francisco, San Francisco, CA.
  • Aggarwal R; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA.
  • Kwon D; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA.
  • McKay R; Department of Medicine, Division of Hematology/Oncology, University of California San Diego, San Diego, CA.
  • Hauger R; Department of Psychiatry and Center for Behavior Genetics of Aging, University of California San Diego, San Diego, CA.
  • Hart N; School of Medical and Health Sciences, Exercise Medicine Research Institute, Edith Cowan University, Joondalup, Western Australia, Australia.
  • Conzen S; Department of Medicine, University of Chicago, Chicago, IL.
  • Borno H; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA.
  • Jim H; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL.
  • Dicker A; Department of Radiation Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA.
  • Dorff T; Department of Medical Oncology and Developmental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA.
  • Moslehi J; Department of Medicine, Cardio-oncology Program, Vanderbilt University Medical Center, Nashville, TN.
  • Mucci L; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA.
  • Parsons JK; Department of Urology, Moores Comprehensive Cancer Center, University of California San Diego, San Diego, CA.
  • Saad F; Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada.
  • Soule H; Prostate Cancer Foundation, Santa Monica, CA.
  • Morgans A; Department of Hematology and Oncology, Northwestern University, Chicago, IL.
  • Ryan CJ; Division of Hematology, Medical Oncology, and Transplantation, University of Minnesota, Minneapolis, MN. Electronic address: ryanc@umn.edu.
Urol Oncol ; 38(3): 83-93, 2020 03.
Article em En | MEDLINE | ID: mdl-31734020

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Continuidade da Assistência ao Paciente / Pesquisa Biomédica Limite: Humans / Male Idioma: En Revista: Urol Oncol Assunto da revista: NEOPLASIAS / UROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Panamá País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Continuidade da Assistência ao Paciente / Pesquisa Biomédica Limite: Humans / Male Idioma: En Revista: Urol Oncol Assunto da revista: NEOPLASIAS / UROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Panamá País de publicação: Estados Unidos